NATIONAL INSTITUTES OF HEALTH
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
African-American Diabetes Intervention Project
- Conditions
- Insulin-Dependent Diabetes Mellitus
- Locations
- 🇺🇸
Case Western Reserve University, Cleveland, Ohio, United States
5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
- Conditions
- Beta Thalassemia
- First Posted Date
- 2000-07-07
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 24
- Registration Number
- NCT00005934
- Locations
- 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
- Conditions
- Prostate CancerProstate Neoplasm
- First Posted Date
- 2000-06-19
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 48
- Registration Number
- NCT00005916
- Locations
- 🇺🇸
National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda, Maryland, United States
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
- Conditions
- Breast CancerBreast Neoplasm
- Interventions
- First Posted Date
- 2000-06-14
- Last Posted Date
- 2013-03-19
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 30
- Registration Number
- NCT00005908
- Locations
- 🇺🇸
National Naval Medical Center, Bethesda, Maryland, United States
Laparoscopy to Remove Pancreatic Tumors (Insulinomas)
- Conditions
- Insulinoma
- First Posted Date
- 2000-06-14
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 23
- Registration Number
- NCT00005910
- Locations
- 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States
Leptin to Treat Lipodystrophy
- Conditions
- Lipodystrophy
- First Posted Date
- 2000-06-12
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 20
- Registration Number
- NCT00005905
- Locations
- 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States
Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
- Conditions
- Mantle Cell LymphomaLymphoma, Mantle Cell
- Interventions
- Drug: EPOCH-RBiological: GM-CSFBiological: Idiotype vaccine
- First Posted Date
- 2000-06-05
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 26
- Registration Number
- NCT00005780
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait
- Conditions
- Sickle Cell Trait
- First Posted Date
- 2000-06-05
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 12
- Registration Number
- NCT00005782
- Locations
- 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States
Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer
- Conditions
- Hematologic NeoplasmHIV Infection
- First Posted Date
- 2000-06-05
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 30
- Registration Number
- NCT00005785
- Locations
- 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
- Conditions
- Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
- First Posted Date
- 2000-05-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 130
- Registration Number
- NCT00005660
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States